Side Effects * Dry cough * Dizziness * Hypotension * Hyperkalemia * Headache * Fatigue * Renal impairment * Angioedema (rare but potentially life-threatening) Contraindications * Pregnancy (especially the second and third trimesters) * History of ACE inhibitor-induced angioedema * Bilateral renal artery stenosis * Significant hyperkalemia * Concomitant use with certain medications in selected patients (e.g., some combinations affecting the reninangiotensin system) Monitoring * Blood pressure * Serum potassium * Serum creatinine and estimated glomerular filtration rate (eGFR) * Clinical signs of hypotension or angioedema Drug Interactions * Potassium supplements and potassium-sparing diuretics may increase the risk of hyperkalemia
Hasegawa Y, Hori M, Nakagami T, Harada-Shiba M, Uchigata Y (2018) Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with statins
Hepatology 72 , 892905 (2020)
Some patients likely saw dramatic improvement while others saw less
A study revealed that TMAO synergizes with gut-derived lipopolysaccharides (LPS) to amplify NF-B activation in dendritic cells, enhancing Th17 differentiation and IL-17 production, which are critical drivers of mucosal damage in UC (102, 103)
In addition, all treatments induced a non-statistically significant trend towards the reduction of stroke volume in comparison with HFD-fed control mice (Fig
